SEARCH

SEARCH BY CITATION

References

  • Angehagen M, Rönnbäck L, Hansson E, Ben-Menachem E. (2005) Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem 94:11241130.
  • Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E. (2005) Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data. Clin Pharmacokinet 44:407416.
  • Choi JW, Kim WK. (2007) Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury? Exp Neurol 203:57.
  • Compagnoni G, Bottura C, Cavallaro G, Cristofori G, Lista G, Mosca F. (2008) Safety of deep hypothermia in treating neonatal asphyxia. Neonatology 93:230235.
  • Costa C, Martella G, Picconi B, Prosperetti C, Pisani A, Di Filippo M, Pisani F, Bernardi G, Calabresi P. (2006) Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke 37:13191326.
  • Dodgson SJ, Shank RP, Maryanoff BE. (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(Suppl 1):S35S39.
    Direct Link:
  • Edmonds HL Jr, Jiang YD, Zhang PY, Shank R. (2001) Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci 69:22652277.
  • Edwards AD, Yue X, Squier MV, Thoresen M, Cady EB, Penrice J, Cooper CE, Wyatt JS, Reynolds EO, Mehmet H. (1995) Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia. Biochem Biophys Res Commun 217:11931199.
  • Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, Sankaran K, Yager JY. (2005) Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol 32:1117.
  • Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE. (2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24:44124420.
  • Gidal BE, Lensmeyer GL. (1999) Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method. Ther Drug Monit 21:567576.
  • Glauser TA, Miles MV, Tang P, Clark P, McGee K, Doose DR. (1999) Topiramate pharmacokinetics in infants. Epilepsia 40:788791.
  • Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ. (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365:663670.
  • Guerrini R, Parmeggiani L. (2006) Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 7:811823.
  • Hoehn T, Hansmann G, Bührer C, Simbruner G, Gunn AJ, Yager J, Levene M, Hamrick SE, Shankaran S, Thoresen M. (2008) Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units. Resuscitation 78:712.
  • Johannessen SI. (1997) Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia 38(Suppl 1):S18S23.
  • Johannessen SI, Tomson T. (2006) Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Clin Pharmacokinet 45:10611075.
  • Kaminski RM, Banerjee M, Rogawski MA. (2004) Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology 46:10971104.
  • Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. (2003) Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 349:11571167.
  • Koh S, Tibayan FD, Simpson JN, Jensen FE. (2004) NBQX or Topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45:569575.
  • Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS. (2004) The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45:14781487.
  • La Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR, Guerrini R. (2008) Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. J Pharm Biomed Anal 48:13921396.
  • Lee SR, Kim SP, Kim JE. (2000) Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett 281:183186.
  • Liu Y, Barks JD, Xu G, Silverstein FS. (2004) Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35:14601465.
  • Mikaeloff Y, Rey E, Soufflet C, D’Athis P, Echenne B, Vallée L, Bouhours P, Grinspan A, Dulac O, Pons G, Chiron C. (2004) Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years. Epilepsia 45:14481452.
  • Morselli P, Franco-Morselli R, Bossi L. (1980) Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet 5:485527.
  • Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, Kim IH, Kim HJ, Kim H, Eun BL. (2006) Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 201:470478.
  • Ohman I, Vitols S, Luef G, Söderfeldt B, Tomson T. (2002) Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 43:11571160.
  • Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E. (2008) Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49:12391276.
  • Perucca E, Bialer M. (1996) The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine. Clin Pharmacokinet 31:2946.
  • Perucca E. (2006) Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 45:351363.
  • Róka A, Melinda KT, Vásárhelyi B, Machay T, Azzopardi D, Szabó M. (2008) Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics 121:e844e849.
  • Rosenfeld WE, Doose DR, Walker SA, Baldassarre JS, Reife RA. (1999) A study of topiramate pharmacokinetics and tolerability in children with epilepsy. Pediatr Neurol 20:339344.
  • Schubert S, Brandl U, Brodhun M, Ulrich C, Spaltmann J, Fiedler N, Bauer R. (2005) Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res 1058:129136.
  • Sfaello I, Baud O, Arzimanoglou A, Gressens P. (2005) Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 20:837848.
  • Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. (2000) An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41(Suppl 1):S3S9.
  • Shank RP, Doose DR, Streeter AJ, Bialer M. (2005) Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Epilepsy Res 63:103112.
  • Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH; National Institute of Child Health and Human Development Neonatal Research Network. (2005) Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353:15741584.
  • Thoresen M, Satas S, Puka-Sundvall M, Whitelaw A, Hallstrom A, Loberg EM, Ungerstedt U, Steen PA, Hagberg H. (1997) Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins. Neuroreport 8:33593362.
  • Tidwell A, Swims M. (2003) Review of the newer antiepileptic drugs. Am J Manag Care 9:253276.
  • Tortorici MA, Kochanek PM, Poloyac SM. (2007) Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med 35:21962204.
  • Yang Y, Shuaib A, Li Q, Siddiqui MM. (1998) Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res 804:169176.
  • Zona C, Ciotti MT, Avoli M. (1997) Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci Lett 231:123126.